# Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy

> **NCT02053064** · PHASE1,PHASE2 · COMPLETED · sponsor: **LYSOGENE** · enrollment: 4 (actual)

## Conditions studied

- Mucopolysaccharidosis Type III A
- Sanfilippo Disease Type A

## Interventions

- **GENETIC:** SAF-301

## Key facts

- **NCT ID:** NCT02053064
- **Lead sponsor:** LYSOGENE
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2013-05
- **Primary completion:** 2017-05
- **Final completion:** 2017-06
- **Target enrollment:** 4 (ACTUAL)
- **Last updated:** 2017-06-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02053064

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02053064, "Long-term Follow-up of Sanfilippo Type A Patients Treated by Intracerebral SAF-301 Gene Therapy". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02053064. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*